(R)-2-(2-((R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine

Catalog No. :
ACDZKR803
CAS No. :
15686-51-8
Molecular Formula :
C21H26ClNO
Molecular Weight :
343.90

IUPAC Name:(R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine

(R)-2-(2-((R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$1222.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-(2-((R)-1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine
IUPAC Name(R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine
Molecular FormulaC21H26ClNO
Molecular Weight343.90
SMILESC[C@@](C1=CC=C(Cl)C=C1)(OCC[C@@]2([H])CCCN2C)C3=CC=CC=C3
InChI KeyYNNUSGIPVFPVBX-NHCUHLMSSA-N
Synonym(2R)-2-(2-((1R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine | clemastine | Clemastinum | SBI-0052796.P003 | AB00053766_09 | BDBM50253157 | DTXSID2022832 | Spectrum4_000955 | 95QN29S1ID | HMS2089I22 | HY-B0298 | SMR001233520 | Tocris-1453
CAS No.15686-51-8
PubChem CID26987

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDZKR803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDZKR803 route product structure diagram
    ACDZKR80315686-51-8
Inquiry

2. ACDZKR803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDZKR803 route product structure diagram
    ACDZKR80315686-51-8
Inquiry

Comments (0)